Clarins SA:企業の戦略・SWOT・財務情報

◆英語タイトル:Clarins SA - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C10175
◆発行会社(調査会社):MarketLine
◆発行日:2018年11月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:南アフリカ
◆産業分野:消費財
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Clarins SA – Strategy, SWOT and Corporate Finance Report
Summary

Clarins SA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Clarins SA (Clarins) is a manufacturer of cosmetic and personal care products. The company primarily offers cleansers, perfumes, anti-aging serums, exfoliators, compacts, concealers, mascaras, lip-care, face treatment oils, UV protectors, sun powders, bath and showers products, bust care, foot care, maternity care, brushes, mascaras, eyeliners, eyebrows, eye primers, and glosses. Clarins also offers personal care products for men such as shaving products, after shave soothers, aging creams, body care, and revitalizing gels. The company also provides services such as beauty tips, gift choice services, and beauty school services. Its products are marketed under Clarins brand. Clarins is headquartered in Johannesburg, South Africa.

Scope

- Detailed information on Clarins SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Clarins SA in the form of a SWOT analysis
- An in-depth view of the business model of Clarins SA including a breakdown and examination of key business segments
- Intelligence on Clarins SA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Clarins SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Clarins SA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Clarins SA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Clarins SA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Clarins SA: Company Overview 8
Clarins SA: Overview and Key Facts 8
Clarins SA: Overview 8
Clarins SA: Key Facts 8
Clarins SA: Key Employees 9
Clarins SA: Key Employee Biographies 10
Clarins SA: Major Products and Services 11
Clarins SA: Company History 12
Clarins SA: Locations and Subsidiaries 14
Clarins SA: Key Competitors 15
Clarins SA: Company Analysis 16
Clarins SA: Business Description 16
Clarins SA: SWOT Analysis 18
Clarins SA: SWOT Overview 18
Clarins SA: Strengths 18
Clarins SA: Weaknesses 19
Clarins SA: Opportunities 19
Clarins SA: Threats 20
Clarins SA: Corporate Financial Deals Activity 21
Clarins SA: Financial Deals Overview 21
Clarins SA: Targets and Partners 22
Clarins SA: Top Deals 2014 – 2018YTD* 23
Clarins SA: Mergers and Acquisitions 24
Clarins SA: Recent Developments 25
Clarins SA: News and Events Summary 25
Clarins SA: Business Expansion 25
Clarins SA: Corporate Governance 26
Clarins SA: Corporate Social Responsibility 26
Clarins SA: Financial Deals 27
Clarins SA: Strategy and Operations 27
Appendix 29
Contact Us 29
Methodology 29
About MarketLine 30

List of Tables
Table 1: Clarins SA: Key Facts
Table 2: Clarins SA: Key Employees
Table 3: Clarins SA: Company History
Table 4: Clarins SA: Locations and Subsidiaries
Table 5: Clarins SA: Key Competitors
Table 6: Clarins SA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Clarins SA: Targets and Partners
Table 8: Clarins SA: Top Deals 2014 - 2018YTD*
Table 9: Clarins SA: M&A Volume and Value Trend (2014 - YTD*2018)
Table 10: Clarins SA: M&A Activity by Geography (2014 - YTD*2018)
Table 11: Clarins SA: News and Events Summary
Table 12: Clarins SA: Business Expansion
Table 13: Clarins SA: Corporate Governance
Table 14: Clarins SA: Corporate Social Responsibility
Table 15: Clarins SA: Financial Deals
Table 16: Clarins SA: Strategy and Operations

List of Figures
Figure 1: Clarins SA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Clarins SA: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 3: Clarins SA: M&A Activity by Geography (2014 - YTD*2018)

★海外企業調査レポート[Clarins SA:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vitrolife AB (VITR):医療機器:M&Aディール及び事業提携情報
    Summary Vitrolife AB (Vitrolife) is a developer, producer and marketer of laboratory products. The company provides products such as follicle aspiration needles, sperm processing, culture media, culture oil, additional culture media, micromanipulation solutions, vitrolife labware, micromanipulation …
  • CiMaas BV:製薬・医療:M&Aディール及び事業提携情報
    Summary CiMaas BV (CiMaas) develops cellular immunotherapies (vaccines) for the treatment of cancer. Its pipeline cellular therapeutic products include CIM101, a dendritic cell vaccine being developed using its proprietary maturation technology for the treatment of lung cancer; and CIM201, a haploid …
  • Population Genetics Technologies Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Population Genetics Technologies Ltd (Population Genetics), a subsidiary of Agilent Technologies Inc is a biotechnology company. The company commercialize nucleic acid biochemistry tools and approaches. Its intellectual property assets include method for normalizing a nucleic acid sample, me …
  • Scynexis Inc (SCYX):製薬・医療:M&Aディール及び事業提携情報
    Summary Scynexis Inc (Scynexis) is a pharmaceutical company that discovers, develops and commercializes novel anti-infective for various therapeutic needs. The company provides pipeline products such as SCY-078, is used for invasive fungal infections; SCY-635, is used for the treatment of Hepatitis …
  • Stratasys Ltd:企業の戦略・SWOT・財務情報
    Stratasys Ltd - Strategy, SWOT and Corporate Finance Report Summary Stratasys Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Binx Health Inc:企業の製品パイプライン分析
    Summary Binx Health Inc (Binx Health), a subsidiary of Binx Health Ltd, is a provider of near-patient and point of care (POC) testing solutions for women’s health. The company develops its proprietary, desktop, PCR-based point-of-care molecular diagnostic platform for diagnosis and treatment for chl …
  • Och-Ziff Capital Management Group LLC (OZM):企業の財務・戦略的SWOT分析
    Summary Och-Ziff Capital Management Group LLC (Oz Management) is an alternative asset management firm that provides asset management services. The firm’s services portfolio includes portfolio management, private investments, funds management, and equity funds investment and management services. Its …
  • Midland Power Cooperative:企業の戦略的SWOT分析
    Midland Power Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Warner Media LLC:企業の戦略的SWOT分析
    Warner Media LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Exxon Mobil Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Exxon Mobil Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Exxon Mobil Corp (ExxonMobil) is an integrated oil and gas company that explores for and produces crude oil and natural gas; manufactures petroleum products; transports and sells crude oil and petro …
  • AMERCO:企業の戦略・SWOT・財務情報
    AMERCO - Strategy, SWOT and Corporate Finance Report Summary AMERCO - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • CRELUX GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Crelux GmbH (Crelux), a subsidiary of WuXi AppTec (Shanghai) Co Ltd, is a drug discovery company that discovers drug solutions for pharmacy, biotech and research organizations. The company offers customized and integrated services in areas of drug discovery, X-ray crystallography, protein su …
  • Isetan Mitsukoshi Holdings Ltd.:企業の戦略・SWOT・財務分析
    Isetan Mitsukoshi Holdings Ltd. - Strategy, SWOT and Corporate Finance Report Summary Isetan Mitsukoshi Holdings Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • The Depository Trust & Clearing Corporation:企業の戦略的SWOT分析
    The Depository Trust & Clearing Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Royal College of Surgeons Ireland-製薬・医療分野:企業M&A・提携分析
    Summary Royal College of Surgeons Ireland (RCSI) is a not-for-profit organization that offers medical education and training in healthcare professions at undergraduate and postgraduate levels. The organization offers undergraduate courses in nursing, postgraduate research, postgraduate taught, leade …
  • MSCI Inc (MSCI):企業の財務・戦略的SWOT分析
    MSCI Inc (MSCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Acasti Pharma Inc (ACST)-製薬・医療分野:企業M&A・提携分析
    Summary Acasti Pharma Inc (Acasti), a subsidiary of Neptune Technologies & Bioressources Inc is a biopharmaceutical company that offers research, development and commercialization of prescription drugs. The company offers products such as Onemia and CaPre. Its CaPre is developed for the prevention a …
  • HESTA Super Fund:企業の戦略的SWOT分析
    HESTA Super Fund - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • ADESA Inc:企業の戦略的SWOT分析
    ADESA Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Concho Resources Inc.:企業の戦略・SWOT・財務情報
    Concho Resources Inc. - Strategy, SWOT and Corporate Finance Report Summary Concho Resources Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆